Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06988787 · ClinicalTrials.gov registry record · NA

Multifaceted Intervention to Restore Resilience and Overcome Risk

A NA study of Post Traumatic Stress Disorder and Intimate Partner Violence, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT06988787: Recruiting NA study of Post Traumatic Stress Disorder and Intimate Partner Violence, sponsored by Icahn School of Medicine at Mount Sinai.

NCT06988787 is a NA study of Post Traumatic Stress Disorder and Intimate Partner Violence that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 136 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06988787, a NA study of Post Traumatic Stress Disorder and Intimate Partner Violence, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The MIRROR study will compare the effectiveness of two interventions in improving emotion regulation and reducing PTSD symptoms in female Veterans with military sexual trauma (MST) and/or intimate partner violence (IPV) and co-occurring brain injury.

Primary Outcome

The DERS is a 36-item self-report measure that assesses emotion dysregulation in six domains: nonacceptance of emotional responses (subscale score 6-30), difficulties engaging in goal directed behavior (subscale score 5-25), impulse control difficulties (subscale score 6-30), lack of emotional awareness (subscale score 6-30), limited access to emotion regulation strategies (subscale score 8-40), and lack of emotional clarity (subscale score 5-25). Items are rated on a scale of 1 ("almost never \

Interventions

  • BEHAVIORAL webSTAIR
  • BEHAVIORAL ExpoTx
  • OTHER PsychoEd

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2025-09-12
Est. Completion 2028-08-01
Phase NA

What NCT06988787 shows while recruiting

NCT06988787 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (79% lower).

The record links to 4 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 3 interventions - of which webSTAIR is the first listed.

NCT06988787 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06988787 about?

NCT06988787 is a clinical study titled "Multifaceted Intervention to Restore Resilience and Overcome Risk". The MIRROR study will compare the effectiveness of two interventions in improving emotion regulation and reducing PTSD symptoms in female Veterans with military sexual trauma (MST) and/or intimate partner violence (IPV) and co-occurring brain injury.

What is the current status of trial NCT06988787?

This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2025-09-12. Estimated completion is 2028-08-01.

What conditions does trial NCT06988787 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Intimate Partner Violence, Brain Injury, Military Sexual Trauma.

What interventions are being tested in trial NCT06988787?

The interventions under investigation include: webSTAIR (BEHAVIORAL), ExpoTx (BEHAVIORAL), PsychoEd (OTHER).

Who is sponsoring clinical trial NCT06988787?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06988787 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06988787's enrollment target sits among peer trials

136 85th of 262 higher than 177 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06988787, the US trial registry maintained by the National Library of Medicine. NCT06988787 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.